Proceeds Agreement Sample Contracts

PROCEEDS AGREEMENT
Proceeds Agreement • May 24th, 2023 • Baker Bros. Advisors Lp • Pharmaceutical preparations

WHEREAS, the Agent, in his capacity as a director of ACADIA Pharmaceuticals Inc. (the “Company”), received non-transferable options (the “Options”) to purchase 12,500 shares of the Company common stock (the “Stock”) according to the below Schedule A;

AutoNDA by SimpleDocs
PROCEEDS AGREEMENT
Proceeds Agreement • January 10th, 2024 • Virginia

This PROCEEDS AGREEMENT, dated [May 14], 2024 (this "Proceeds Agreement"), is among the VIRGINIA PUBLIC SCHOOL AUTHORITY, a public body corporate and instrumentality of the Commonwealth of Virginia ("VPSA"), and the counties and

PROCEEDS AGREEMENT
Proceeds Agreement • May 9th, 2024 • Baker Bros. Advisors Lp • Services-commercial physical & biological research

WHEREAS, the Agent, in his capacity as a director of Incyte Corporation (the “Company”), received non-transferable options (the “Options”) to purchase 15,000 shares of the Company common stock (the “Stock”) according to the below Schedule A;

PROCEEDS AGREEMENT
Proceeds Agreement • February 28th, 2019 • Baker Bros. Advisors Lp • Services-medical laboratories • New York

WHEREAS, the Agent, in his capacity as a director of Genomic Health, Inc. (the “Company”), received non-transferable options (the “Options”) to purchase 8,250 shares of the Company common stock (the “Stock”) according to the below Schedule A;

PROCEEDS AGREEMENT
Proceeds Agreement • January 30th, 2017 • Baker Bros. Advisors Lp • Biological products, (no disgnostic substances) • New York

AGREEMENT dated as of January 26, 2017 by and between Baker Bros. Advisors LP (the “Management Company”) and Michael Goller (the “Agent”).

PROCEEDS AGREEMENT
Proceeds Agreement • May 3rd, 2018 • Baker Bros. Advisors Lp • Services-commercial physical & biological research • New York

WHEREAS, the Agent, in his capacity as a director of Incyte Corporation (the “Company”), received non-transferable options (the “Options”) to purchase 20,000 shares of the Company common stock (the “Stock”) according to the below Schedule A;

PROCEEDS AGREEMENT
Proceeds Agreement • May 19th, 2016 • Baker Julian • Services-medical laboratories • New York

WHEREAS, the Agent, in his capacity as a director of Genomic Health, Inc. (the “Company”), received non-transferable options (the “Options”) to purchase 8,250 shares of the Company common stock (the “Stock”) according to the below Schedule A;

PROCEEDS AGREEMENT
Proceeds Agreement • March 17th, 2016 • Baker Julian • Services-commercial physical & biological research • New York

WHEREAS, the Agent, in his capacity as a director of Incyte Corporation (the “Company”), received non-transferable options (the “Options”) to purchase 20,000 shares of the Company common stock (the “Stock”) according to the below Schedule A;

PROCEEDS AGREEMENT
Proceeds Agreement • February 16th, 2016 • Baker Bros. Advisors Lp • Biological products, (no disgnostic substances) • New York

AGREEMENT dated as of February 11, 2016 by and between Baker Bros. Advisors LP (the “Management Company”) and Michael Goller (the “Agent”).

PROCEEDS AGREEMENT
Proceeds Agreement • June 1st, 2017 • Baker Bros. Advisors Lp • Services-medical laboratories • New York

WHEREAS, the Agent, in his capacity as a director of Genomic Health, Inc. (the “Company”), received non-transferable options (the “Options”) to purchase 8,250 shares of the Company common stock (the “Stock”) according to the below Schedule A;

PROCEEDS AGREEMENT
Proceeds Agreement • April 28th, 2017 • Baker Bros. Advisors Lp • Services-commercial physical & biological research • New York

WHEREAS, the Agent, in his capacity as a director of Incyte Corporation (the “Company”), received non-transferable options (the “Options”) to purchase 20,000 shares of the Company common stock (the “Stock”) according to the below Schedule A;

PROCEEDS AGREEMENT
Proceeds Agreement • April 29th, 2020 • Baker Bros. Advisors Lp • Services-commercial physical & biological research • New York

WHEREAS, the Agent, in his capacity as a director of Incyte Corporation (the “Company”), received non-transferable options (the “Options”) to purchase 20,000 shares of the Company common stock (the “Stock”) according to the below Schedule A;

PROCEEDS AGREEMENT
Proceeds Agreement • June 26th, 2018 • Baker Bros. Advisors Lp • Biological products, (no disgnostic substances) • New York

WHEREAS, the Agent, in his capacity as a director of DBV Technologies S.A. (the “Company”), received non-transferable warrants (the “Warrants”) to purchase 7,000 shares of the Company common stock (the “Stock”) according to the below Schedule A;

PROCEEDS AGREEMENT
Proceeds Agreement • March 12th, 2018 • Baker Bros. Advisors Lp • Services-medical laboratories • New York

WHEREAS, the Agent, in his capacity as a director of Genomic Health, Inc. (the “Company”), received non-transferable options (the “Options”) to purchase 8,250 shares of the Company common stock (the “Stock”) according to the below Schedule A;

EXHIBIT E PROCEEDS AGREEMENT [HSBC Bank USA Letterhead] December 14, 2005
Proceeds Agreement • December 20th, 2005 • Royal Gold Inc • Mineral royalty traders

This is to advise you that HSBC Bank USA (“HSBC”) has continued a credit facility in favor of Royal Gold, Inc. (“Royal Gold”) pursuant to the Amended and Restated Loan Agreement dated as of December 14, 2005 between HSBC and Royal Gold (the “Loan Agreement”), which amends and restates in its entirety the Loan Agreement dated as of December 18, 2000 between HSBC and Royal Gold. The Loan Agreement is secured by various collateral security arrangements, including: (1) a lien and security interest in favor of HSBC on Royal Gold’s share of all mineral production (“Production”) from the GSR#1 Royalty, the GSR#3 Royalty and the NVR#1 Royalty, each on the Pipeline/South Pipeline Mining Complex in Lander County, Nevada (the “Project”), (2) a security interest in all proceeds of such Production (“Proceeds”), and (3) a security interest in all accounts of Royal Gold, whether metals or monetary, and credit balances therein, with Johnson Matthey Inc. (“Accounts”).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!